Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

651 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Estimated Population Health Benefits of Intensive Systolic Blood Pressure Treatment Among SPRINT-Eligible US Adults.
Derington CG, Bress AP, Berchie RO, Herrick JS, Shen J, Ying J, Greene T, Tajeu GS, Sakhuja S, Ruiz-Negrón N, Zhang Y, Howard G, Levitan EB, Muntner P, Safford MM, Whelton PK, Weintraub WS, Moran AE, Bellows BK. Derington CG, et al. Among authors: weintraub ws. Am J Hypertens. 2023 Aug 5;36(9):498-508. doi: 10.1093/ajh/hpad047. Am J Hypertens. 2023. PMID: 37378472
Identifying Patients for Intensive Blood Pressure Treatment Based on Cognitive Benefit: A Secondary Analysis of the SPRINT Randomized Clinical Trial.
Ghazi L, Shen J, Ying J, Derington CG, Cohen JB, Marcum ZA, Herrick JS, King JB, Cheung AK, Williamson JD, Pajewski NM, Bryan N, Supiano M, Sonnen J, Weintraub WS, Greene TH, Bress AP. Ghazi L, et al. Among authors: weintraub ws. JAMA Netw Open. 2023 May 1;6(5):e2314443. doi: 10.1001/jamanetworkopen.2023.14443. JAMA Netw Open. 2023. PMID: 37204788 Free PMC article. Clinical Trial.
The burden of cardiovascular disease attributable to high systolic blood pressure across China, 2005-18: a population-based study.
Cao X, Zhao Z, Kang Y, Tian Y, Song Y, Wang L, Zhang L, Wang X, Chen Z, Zheng C, Tian L, Yin P, Fang Y, Zhang M, He Y, Zhang Z, Weintraub WS, Zhou M, Wang Z; China Burden of Disease Attributable to Risk Factors Collaborative Group. Cao X, et al. Among authors: weintraub ws. Lancet Public Health. 2022 Dec;7(12):e1027-e1040. doi: 10.1016/S2468-2667(22)00232-8. Lancet Public Health. 2022. PMID: 36462514 Free article.
Diagnosing coronary artery disease and cost of care.
Weintraub WS. Weintraub WS. J Cardiovasc Comput Tomogr. 2023 Jan-Feb;17(1):60-61. doi: 10.1016/j.jcct.2022.11.005. Epub 2022 Nov 29. J Cardiovasc Comput Tomogr. 2023. PMID: 36604293 No abstract available.
The Economic Burden of Illness.
Weintraub WS. Weintraub WS. JAMA Netw Open. 2023 Mar 1;6(3):e232663. doi: 10.1001/jamanetworkopen.2023.2663. JAMA Netw Open. 2023. PMID: 36912842 Free article. No abstract available.
Impact of Complete Revascularization in the ISCHEMIA Trial.
Stone GW, Ali ZA, O'Brien SM, Rhodes G, Genereux P, Bangalore S, Mavromatis K, Horst J, Dressler O, Poh KK, Nath RK, Moorthy N, Witkowski A, Dwivedi SK, Bockeria O, Chen J, Smanio PEP, Picard MH, Chaitman BR, Berman DS, Shaw LJ, Boden WE, White HD, Fremes SE, Rosenberg Y, Reynolds HR, Spertus JA, Hochman JS, Maron DJ; ISCHEMIA Research Group. Stone GW, et al. J Am Coll Cardiol. 2023 Sep 19;82(12):1175-1188. doi: 10.1016/j.jacc.2023.06.015. Epub 2023 Jul 17. J Am Coll Cardiol. 2023. PMID: 37462593 Clinical Trial.
651 results